While lowering drug prices for Americans is important, doing so through IRP is ill-advised.
A unique Curta technology that lets clients perform in-document queries of complex reports.
Dr. Scott Ramsey spoke at the ASCO Clinical Science Symposium: The Future of Cancer Detection…
A full agenda of expert-led sessions, research presentations, and more.
Dr. Grueger will work closely with the Curta Global Market Access team, led by Dr. Sean…
Supreme Court Case Could Threaten Preventive Cancer Screenings, Dr. Scott Ramsey Tells STAT A recent…
We’re thrilled to share that Curta researchers Elizabeth Brouwer and Jimmy Tan along with co-author…
Molecular testing is essential for precision medicine. Yet, not all patients have equitable access.
In this newly published paper, David Veenstra, Noemi F. Brennan, and Sarah Katsandres of Curta,…
Mis-matched incentives and other challenges in biosimilar development and uptake threaten sustainability across global markets.
In a new study co-authored by Curta researchers, the introduction of a new bioengineered human…
Curta leadership will be attending the World Evidence, Pricing, and Access (EPA) Congress in Amsterdam…
